Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | TUBB4A | P04350 | 5/20 | 1.00 |
| ▸ | TUBB | P07437 | 5/20 | 1.00 |
| ▸ | TUBA3C | P0DPH7 | 5/20 | 1.00 |
| ▸ | TUBA1B | P68363 | 5/20 | 1.00 |
| ▸ | TUBA4A | P68366 | 5/20 | 1.00 |
| ▸ | TUBB4B | P68371 | 5/20 | 1.00 |
| ▸ | TUBB3 | Q13509 | 5/20 | 1.00 |
| ▸ | TUBB2A | Q13885 | 5/20 | 1.00 |
| ▸ | TUBB8 | Q3ZCM7 | 5/20 | 1.00 |
| ▸ | TUBA3E | Q6PEY2 | 5/20 | 1.00 |
| ▸ | TUBA1A | Q71U36 | 5/20 | 1.00 |
| ▸ | TUBA1C | Q9BQE3 | 5/20 | 1.00 |
| ▸ | TUBB6 | Q9BUF5 | 5/20 | 1.00 |
| ▸ | TUBB2B | Q9BVA1 | 5/20 | 1.00 |
| ▸ | TUBB1 | Q9H4B7 | 5/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Noscapine SCHEMBL7862895 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL14386820 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL29365828 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL10307295 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL2494164 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL12481369 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL14400084 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL1405962 | 0.99 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL29387578 | 0.99 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL177962 | 0.99 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15903 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748375-A1 | PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING ORGAN FIBROSIS-RELATED DISEASES | Shionogi China Co., Ltd. (CN) | 2026-05-27 | — | — | EP | claimed |
| CN-122072257-A | Method for rapidly detecting poison in blood | 中国科学院大连化学物理研究所 | 2026-05-22 | — | — | CN | claimed |
| CN-122055143-A | Solid compositions containing bromhexine | 第一三共健康事业株式会社 | 2026-05-15 | — | — | CN | claimed |
| US-20250388939-A1 | RECOMBINANT HOST CELLS WITH IMPROVED PRODUCTION OF L-DOPA, DOPAMINE, S-NOROCLAURINE OR DERIVATIVES THEREOF | RIVER STONE BIOTECH APS (DK) | 2025-12-25 | — | — | US | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-20250248938-A1 | MEDICAMENT DELIVERY FORMULATIONS, DEVICES AND METHODS | HONEYWELL INTERNATIONAL INC. (US) | 2025-08-07 | — | — | US | claimed |
| US-12371722-B2 | Recombinant host cells with improved production of L-DOPA, dopamine, S-noroclaurine or derivatives thereof | RIVER STONE BIOTECH APS (DK) | 2025-07-29 | — | — | US | claimed |
| US-20250188090-A1 | A METHOD FOR EXTRACTION OF ALKALOID | SUN PHARMACEUTICAL INDUSTRIES (AUSTRALIA) PTY LTD (AU) | 2025-06-12 | — | — | US | claimed |
| US-20250179543-A1 | NORCOCLAURINE SYNTHASES WITH INCREASED ACITVITY | RIVER STONE BIOTECH INC (US) | 2025-06-05 | — | — | US | claimed |
| WO-2025100462-A1 | SOLID COMPOSITION CONTAINING BROMHEXINE | 第一三共ヘルスケア株式会社 | 2025-05-15 | — | — | WO | claimed |
| EP-0233932-A4 | ANTICONVULSANT COMPOSITIONS AND METHOD. | UNIV NEW YORK (US) | 1988-04-26 | — | — | EP | claimed |
| EP-0241615-A1 | A pharmaceutical composition of phenindamine having enhanced release characteristics | WARNER-LAMBERT COMPANY (US) | 1987-10-21 | — | — | EP | claimed |
| EP-0233932-A1 | ANTICONVULSANT COMPOSITIONS AND METHOD | NEW YORK UNIVERSITY (US) | 1987-09-02 | — | — | EP | claimed |
| EP-0219458-A2 | Medicament adsorbates and their preparation | WARNER-LAMBERT COMPANY (US) | 1987-04-22 | — | — | EP | claimed |
| US-4650663-A | FLAKES, INTERSTITIAL SPACES | WARNER-LAMBERT COMPANY (US) | 1987-03-17 | — | — | US | claimed |
| WO-1987001036-A1 | ANTICONVULSANT COMPOSITIONS AND METHOD | NEW YORK UNIVERSITY (US) | 1987-02-26 | — | — | WO | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| EP-0132472-A1 | Medicated products containing a magnesium trisilicate adsorbent with a medicament drug adsorbed thereon | WARNER-LAMBERT COMPANY (US) | 1985-02-13 | — | — | EP | claimed |
| US-4369172-A | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose | FOREST LABORATORIES INC. (US) | 1983-01-18 | — | — | US | claimed |
| US-4029797-A | Process of making cough syrup with masked noscapine | FISONS CORPORATION (US) | 1977-06-14 | — | — | US | claimed |